Leveraging engineered mitochondria through intercellular communication network for accelerated transport and delivery

Area of Science:

• Cell Biology
• Mitochondrial Biology
• Drug Delivery Systems

Background:

• Mitochondria play crucial roles in cellular communication and energy metabolism.
• Intercellular mitochondrial transfer is a natural process observed in cell-to-cell communication.
• Current drug delivery methods face challenges in penetrating biological barriers like tumors.

Purpose of the Study:

• To explore methods for accelerating mitochondrial intercellular transport.
• To develop a novel platform for exogenous cargo delivery using engineered mitochondria.
• To investigate the therapeutic potential of mitochondria-mediated drug delivery for cancer treatment.

Main Methods:

• Downregulation of PINK1-targeted mitophagy to enhance mitochondrial transit capacity.
• Engineering mitochondria as vehicles for photosensitizer cargo.
• Utilizing tunneling nanotubes (TNTs) for intercellular cargo transport.
• Spatiotemporal tracking to monitor mitochondrial transit and physiological effects.

Main Results:

• PINK1-targeted mitophagy downregulation significantly increased mitochondrial transit capacity.
• Engineered mitochondria effectively transported photosensitizers via TNTs.
• Enhanced intercellular delivery led to deep tumor penetration and improved photodynamic killing.
• Demonstrated multifaceted drivers including morphological adaptation, metabolic reprogramming, and respiratory enhancement.

Conclusions:

• Mitochondria can be engineered as efficient vehicles for intercellular cargo delivery.
• This mitochondria-hitchhiking platform overcomes biological barriers for enhanced drug delivery.
• The study provides mechanistic insights into manipulating organelle transport for therapeutic applications.